compared. A second possible cause is that, with few exceptions, [23] [24] [25] whole mite extracts have been used for cross-inhibition. The allergen extracts are difficult to standardize, and different allergenic components in the extracts cross-react to various extents. In a few cases in which separate components in extracts of different mite species have been studied, an allergenic component with an approximate molecular weight (MW) of 15 kd has been shown to cross-react between different mite species. [18] [19] 22, [26] [27] The 15-kd components probably correspond to group 2 mite allergens, which have been recognized as major allergens in a number of mite species. 28 Several of these allergens have been cloned and expressed as recombinant proteins, among them Der p 2 from Dermatophagoides pteronyssinus, 29 Lep d 2 from L destructor, 30 and Tyr p 2 from T putrescentiae. 31 The group 2 allergens are all members of the same family of related proteins and show various degrees of homology. When aligned, Lep d 2 and Tyr p 2 share 43% identical residues, Lep d 2 and Der p 2 share 37% identical residues, and Tyr p 2 and Der p 2 share 40% identical residues. The tertiary structures of Der p 2 32 and Der f 2 from the related dust mite Dermatophagoides farinae 33 have been determined by means of nuclear magnetic resonance, and the results show that the group 2 mite allergens are not homologous to any other known protein family. The biologic function of these proteins is also unknown.
L destructor and G domesticus are 2 phylogenetically closely related mite species, and a high degree of crossinhibition between L destructor and G domesticus extracts has been reported. 16 No allergens from G domesticus have been characterized on the molecular level. We here report the cloning and expression in Escherichia coli of the group 2 allergen from G domesticus, named Gly d 2. * Gly d 2 shows a much higher sequence homology to Lep d 2 (79%) than to other characterized group 2 allergens. It is therefore of interest to study the crossreactivity between Gly d 2 and Lep d 2, as well as that between Gly d 2 and other group 2 allergens, including the major indoor dust mite allergen Der p 2. This is also relevant considering that these allergens exist in the same, as well as separate, environments.
METHODS

Preparation of mite extracts, purification, and protein sequencing of Gly d 2
Mite extracts were prepared from whole mite cultures obtained from Allergon AB (Ängelholm, Sweden), as previously described. 19 G domesticus extract was made 60% saturated with ammonium sulphate, the desalted soluble fraction was run on a 15% SDS-PAGE, and the separated proteins were electroblotted to a polyvinylidene fluoride (PVDF) membrane (Immobilon-PSQ; Millipore, Bedford, Mass). An approximately 15-kd Coomassie Brilliant Blue R250-stained band was cut out and directly subjected to N-terminal protein sequence analysis in a Perkin Elmer ABI 494 Procice cLC protein sequencer (Perkin Elmer, Foster City, Calif).
Isolation of mRNA and PCR amplification
G domesticus mRNA was isolated from 1 g of living mites (Allergon AB) by using Straight A's mRNA isolation system (Novagen Inc, Madison, Wis). cDNA synthesis, second-strand synthesis, adaptor ligation, and rapid amplification of cDNA ends (RACE) reactions were carried out by using the Marathon cDNA Amplification kit (Clontech, Palo Alto, Calif). 3'RACE was performed with a degenerate primer corresponding to the N-terminal amino acid sequence of the 15 kd protein from G domesticus extract,GGCAAGATGAACTT(C/T)AA(A/G)GA(C/T)TG(C/T)GG, and the AP1 primer (Clontech) corresponding to the adaptorsequence. 5'RACE was performed with a gene-specific primer, CGCATGCCATGACACCGTGGTCAC, and the AP1 primer (Clontech). The entire coding sequence of Gly d 2 was amplified in a PCR+1 reaction. 34, 35 In the PCR+1 method the DNA template is asymmetrically amplified, and a third primer containing a 5' restriction site is added to a last cycle of amplification. Freshly prepared adapter-ligated cDNA (Advantage 2 PCR-kit, Clontech) was amplified with a 5' primer, GCGGTCGTTTCGGCCGGCAAGAT (the underlined GGC codon corresponds to the N-terminal glycine residue in the mature G domesticus protein), and a 3' primer in 5-fold excess over the 5' primer, ATTGATTTATTTTCGACTTGTCC (underlined is the stop codon). In a final PCR cycle, a PCR+1 primer, AGATCTGCGGTCGTTTCGGCCGGCAAGAT (underlined is a BglII-restriction site), was added. The PCR product was blunt-end cloned into pT7 Blue vector by using the Perfectly Blunt Cloning kit (Novagen), and PCR+1 clones were identified by cleavage of plasmid DNA with BglII and EcoRI (all restriction endonucleases from New England Biolabs Inc, Beverly, Mass), and analysis of restriction fragments were identified by agarose electrophoresis.
DNA sequencing
Plasmid DNA was sequenced in an ABI 377 sequencer (Perkin Elmer) by using the ABI PRISM dRhodamine Terminator Cycle Sequencing Ready Reaction kit (Perkin Elmer) with a T7-promoter and T7-terminator primer (Novagen) for sequencing of pET-clones and a T7-promoter and M13-primer (Perkin Elmer) for pT7-Blue clones. Sequence alignments were obtained by using the DNAS-TAR MegAlign program (DNASTAR Inc, Madison, Wis).
Cloning into pET 17b and expression in E coli
A PCR+1 clone was used as the template to PCR amplify DNA encoding the mature Gly d 2 protein. The 5' primer, TCTAGA-CATATGGGCAAGATGAAGTTTAAGGAT, introduces a start codon (underlined) 5' of the GGC encoding the N-terminal glycine in the mature protein, and the 3' primer, GGATCCAAGCTTAGTG-GTGATGGTGATGGTGGTCGACTTGCCGGCCGAA, includes 6 histidine codons before the stop codon (underlined). The primers also included restriction enzyme sites (bold), NdeI in the 5' primer and 
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HindIII in the 3' primer. The NdeI-HindIII-digested PCR product was cloned into the expression vector pET 17 b (Novagen) at the NdeI and HindIII sites. The pET vector containing the Gly d 2 insert was initially transformed into a nonexpressing E coli strain, XL-2 Blue, and thereafter to the expression strain BL21 (DE3) pLysS (Novagen). Expression was performed according to the protocol for the pET expression system (Novagen). The expressed recombinant protein was mainly recovered as inclusion bodies, which were solubilized in 20 mmol/L TRIS-HCl (pH 8.0), 100 mmol/L NaCl, and 6 mol/L guanidinium hydrochloride. His-tagged recombinant protein was affinity purified by using immobilized metal affinity chromatography (Talon, Clontech) and eluted from the resin with 100 mmol/L imidazol, 20 mmol/L TRIS-HCl (pH 8), and 100 mmol/L NaCl. The recombinant protein was subsequently dialyzed against PBS. 36 ), rTyr p 2, and rDer p 2.0101 (D1S) were expressed with 6 histidine tags at their C-termini and purified as described elsewhere. 31, 37, 38 Each recombinant group 2 allergen inhibited, in a dose-dependent manner, IgE binding to 14-to 16-kd (approximate MW) components in the corresponding extracts. Recombinant Gly d 2 was prepared as described in the previous section.
Recombinant allergens
Analysis of rGly d 2 by means of size-exclusion chromatography
G domesticus extract (0.5 mg) and rGly d 2 (0.5 mg) were subjected to size-exclusion chromatography on a Superose-12 FPLC column (Amersham Pharmacia Biotech, Uppsala, Sweden) in PBS. The column was calibrated with BSA (67 kd), ovalbumin (43 kd), chymotrypsinogen A (25 kd), and RNase A (13.7 kd). Fractions were collected and analyzed by using ELISA or immunoblotting with a polyclonal rabbit antiserum raised against rLep d 2, which also recognizes a 15-kd component in G domesticus extract and rGly d 2.
Serum samples
Sera were obtained from farmers who had previously participated in an epidemiologic investigation of respiratory diseases. 39 A serum pool was prepared containing equal amounts of 7 individual sera. Each serum in the pool was positive to G domesticus, L destructor, T putrescentiae, and D pteronyssinus, with IgE ranging from 1.0 to 25.4 k A U/L (Pharmacia CAP System RAST FEIA; Pharmacia and Upjohn Diagnostics AB, Uppsala, Sweden), and also shown by immunoblotting to react with an IgE-binding component of 15 kd (approximate MW) in G domesticus, L destructor, T putrescentiae, and D pteronyssinus extracts. A serum with high RAST values for several pollen allergens but negative to mite allergens was used as negative control.
SDS-PAGE and Western blot analysis
SDS-PAGE was performed under nonreducing conditions by using 15% SDS polyacrylamide gels. For extract, 15 µg/mm and for recombinant allergens, 0.2 µg/mm was loaded onto the gel. Separated proteins were blotted onto Immobilon-P PVDF membranes (Millipore). Immunodetection with human sera was performed as described earlier 19 with the serum pool or individual sera at a dilution of 1:4, affinity-purified rabbit anti-human IgE (Miab, Uppsala, Sweden), and alkaline phosphatase-conjugated goat anti-rabbit IgG (Dako A/S, Glostrup, Denmark). Finally, the IgE-binding proteins were visualized by using an Alkaline Phosphatase Conjugate Substrate Kit (Bio-Rad, Richmond, Va).
Blotting inhibition
Recombinant Gly d 2, rTyr p 2, rLep d 2, and rDer p 2 were used as inhibitors in the cross-reactivity experiments. The serum pool or individual sera (final dilution, 1:4) were preincubated for 1 hour at room temperature with 1 or 10 µg of inhibitor. The mixtures were then incubated with membrane strips, and the allergenic components were visualized as described in the previous section.
Calculation of inhibition results
The PVDF membrane strips were evaluated by means of densitometry scanning with a Bio-Rad Model GS-670 Imaging Densitometer and the Molecular Analyst Software version 2.1. The OD value for each recombinant allergen incubated with serum only (without inhibitor) was taken as 100% binding of IgE (A). Background values (0% IgE binding) were obtained from strips with recombinant allergen incubated with control serum (B). Inhibition was calculated by using the following formula:
where X is the OD value obtained for PVDF strips with recombinant allergen incubated with serum and inhibitor and A and B are as above.
Molecular modeling
Models were generated by using the rDer p 2.0101 (D1S) x-ray crystal structure as a template. The crystallography results will be discussed elsewhere; however, there is good agreement between the tertiary structure determined by means of x-ray crystallography and the nuclear magnetic resonance structure reported by Mueller et al. 32 Modeling was conducted by using standard homology modeling methods. SYBYL (Tripos, Inc, St Louis, Mo) was used for insertions or deletions of 1 to 3 amino acid residues, local minimization, sequence alignment, and viewing of the resulting structures. The molecular modeling program CONGEN (Congenomics Inc, Princeton, NJ) was used for amino acid substitutions, side chain reconstitution, energy minimization, and molecular dynamics. In all cases the lowest energy conformer was selected for further consideration. The final figures were produced by using MIDAS software (UCSF Computer Graphics Laboratory, San Francisco, Calif). 
RESULTS
Isolation
IgE binding to native and recombinant Gly d 2
Seventeen sera RAST-positive to G domesticus were tested in immunoblotting experiments, and 16 sera recognized a protein with an approximate MW of 15 kd in G domesticus extract (Fig 2, A) . The same 16 sera exhibited IgE binding to rGly d 2 (Fig 2, B) , and 7 of these sera were included in the serum pool later used in cross-inhibition experiments. The recombinant Gly d 2 inhibited in a dose-dependent manner (0.01, 0.1, 1, and 10 µg inhibitor) the IgE binding of the serum pool to a 15-kd (approximate MW) component in the G domesticus extract (not shown). At the highest dose tested (ie, 10 µg), the inhibition was 77%. The higher MW bands present on the rGly d 2 immunoblot strips (Fig 2, B) probably correspond to multimers of the allergen because IgE binding to these bands was inhibited to the same extent as to the monomers in the inhibition experiments (not shown). When rGly d 2 was run in size-exclusion chromatography, rGly d 2 eluted as a broad peak corresponding to approximate MWs between 15 and 30 kd, whereas native Gly d 2 in G domesticus extract eluted as a more distinct peak corresponding to 15 kd. However, on SDS-PAGE, the eluted fractions were shown to contain mainly 15-kd components and less than 10% 30-kd components. This was also confirmed by protein staining of blotting membranes with rGly d 2. 
Cross-inhibition of IgE binding to rGly d 2 in individual sera
Ten G domesticus-positive sera were used in inhibition experiments to examine the cross-reactivity of Gly d 2 to other group 2 allergens. As shown in Table I , IgE binding to rGly d 2 was completely inhibited by rLep d 2 in all 10 sera. Extensive inhibition was also obtained with rTyr p 2 in all sera, whereas rDer p 2 inhibited IgE binding to rGly d 2 in some sera but not in others (Table I) .
Cross-inhibition of IgE binding to rGly d 2, rLep d 2, rTyr p 2, and rDer p 2
Cross-inhibition of IgE binding to the recombinant group 2 allergens was studied in the serum pool. In Table  II the numerical values of the inhibition, as calculated from densitometry scanning of immunoblots of rGly d 2, rLep d 2, rTyr p 2, and rDer p 2, are given. In all cases the homologous inhibition of recombinant allergens is 90% or greater. Furthermore, rLep d 2 almost complete- 
Molecular modeling of Gly d 2, Lep d 2, and
Tyr p 2 and comparison with the tertiary structure of Der p 2 Fig 3 shows models of the nonpyroglyphid mite group 2 allergens superimposed on the crystal structure of rDer p 2. The models show essentially identical secondary and tertiary structures. Minor differences occur in loop positions and at the carboxyl termini. The core residues are either maintained or substituted with conservative amino acids. The majority of sequence differences are located on the solvent-exposed surface.
DISCUSSION
In this study we examined the specific cross-inhibition capacity among group 2 allergens of G domesticus, L destructor, T putrescentiae, and D pteronyssinus by using pure recombinant allergens. The group 2 allergen of G domesticus, Gly d 2, has not been characterized before, and we here report on the cloning and expression of this new allergen. During the cloning procedure, we observed that several isoforms of Gly d 2 exist, which is in agreement with what has been reported for group 2 allergens. [30] [31] 40 We have earlier applied the PCR+1 method for cloning of isoforms of Lep d 2 30 and Tyr p 2. 31 This method was developed to circumvent problems with artifactual DNA sequences arising when polymorphic DNA is amplified and subcloned into bacteria, which will repair mismatches randomly during replication. 34 Two isoforms of Gly d 2 were isolated, but only one of these isoforms was able to inhibit IgE binding to native Gly d 2 in G domesticus extract, indicating that it is a more commonly occurring isoform in the G domesticus extract. Probably more than these 2 isoforms exist because none of them was identical to the deduced N-terminal protein sequence. When Gly d 2 was expressed in E coli, the resulting recombinant protein seems to form both monomers and multimers, as shown on immunoblots of rGly d 2. The multimers may be a result of improper folding and disulphide bridge formation in the bacteria or incorrect refolding and aggregation after solubilization of inclusion bodies. However, size-exclusion chromatography of rGly d 2 showed that the majority of rGly d 2 molecules are found as monomers.
We conclude that Gly d 2 is a major allergen of G domesticus because 16 of 17 G domesticus RAST-positive subjects had IgE that bound both to a 15-kd component in G domesticus extract and to rGly d 2. Recombinant Gly d 2 was also able to inhibit IgE binding to a native 15-kd component in G domesticus extract. However, the inhibition was not complete, which might be due to the presence of multiple Gly d 2 isoforms or other allergens in the same MW range in the extract. For example, Der p 5 has an apparent MW of 14 kd, 41, 42 and a 13-kd allergen homologous to fatty acid-binding proteins and denoted as group 13 mite allergen has been identified in the nonpyroglyphid mites Blomia tropicalis and Acarus siro. 43, 44 We have also recently identified 2 new allergens in L destructor that are homologous to group 5 and group 13 allergens (manuscript in press).
The protein sequence identity between group 2 allergens from different dust mite species ranges from around 35% to over 85% (the latter figure for species within the same genus, ie, D pteronyssinus and D farinae). Gly d 2 is 79% identical to Lep d 2, which is in agreement with the close phylogenetic relationship between G domesticus and L destructor, but only around 40% identical to Tyr p 2 and Der p 2.
Our results showed extensive cross-reactivity among Gly d 2, Lep d 2, and Tyr p 2. The fact that rLep d 2 caused almost complete inhibition of IgE binding to rGly d 2 and rTyr p 2 may reflect that the sera used in this study originate from a farming population that is heavily exposed to L destructor. 45 Similar observations have been made in studies in which sera from populations primarily sensitized to Dermatophagoides species have been used. Only Dermatophagoides extracts were able to completely inhibit IgE binding of these sera to other mite extracts. 12, 21, 22 We observed only limited cross-inhibition between Der p 2 and the 3 nonpyroglyphid mite allergens. This observation is in agreement with some studies but not others. No or only limited cross-inhibition could be demonstrated between D pteronyssinus and L destructor or T putrescentiae in 2 studies. 12, 16 Other studies have shown that D pteronyssinus extract can inhibit IgE binding to L destructor and T putrescentiae extracts, but L destructor or T putrescentiae extracts did not inhibit IgE binding to D pteronyssinus. 14 18, 19 also demonstrated limited cross-inhibition between 15-and 16-kd components in D pteronyssinus, L destructor, and T putrescentiae extracts. The conflicting results obtained in studies on cross-reactivity probably reflect the different origins of sera used. The mite exposure varies widely in populations, and the degree of exposure may influence how many and to which epitopes in a single allergen the IgE response is raised. The IgE epitopes of group 2 allergens might either be common to several mite species or specific to a single allergen. Therefore exposure to different compositions of mite fauna probably affects how allergens from different mite species cross-react.
The extensive cross-inhibition among rGly d 2, rLep d 2, and rTyr p 2 compared with the limited cross-inhibition between these allergens and rDer p 2 is interesting from a structural point of view. Although the amino acid sequence identity between Der p 2 and the nonpyroglyphid mite allergens is only approximately 40%, the structure models generated in this study predict that the alpha carbon backbone tertiary structures of the nonpyroglyphid mite allergens are essentially identical to the Der p 2 structure. The majority of the sequence differences correspond to the amino acid side chains that reside on the solvent-accessible surface. The differences in antibody binding can thus be attributed to changes in surface topology because of these substitutions and not global changes in the 3-dimensional structure.
The observation on the lack of cross-reactivity between Der p 2 and the 3 nonpyroglyphid mite group 2 allergens is of clinical importance when diagnostic methods on the basis of recombinant allergens are developed. Thus allergens from different mite species, as well as allergens other than the group 2 allergens, have to be taken into account to obtain reliable tools for diagnosis and treatment of dust mite allergy.
Protein sequence analysis was carried out at the Protein Analysis Centre, Karolinska Institutet, Stockholm, Sweden.
